Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIDA award supports Ensysce's development of opioid overdose protection platform

Sep. 19, 2018

NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder

Sep. 13, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Addicted to bile acids

Aug. 2, 2018

First cohort dosed in phase I study of OMS-527

July 18, 2018

The locus of alcohol's reward

June 29, 2018

Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527

June 28, 2018

DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns

June 25, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...